{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:10:33Z","timestamp":1789560633553,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Genetic Engineering and Biotechnology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jgeb.2026.100771","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:30:13Z","timestamp":1785803413000},"page":"100771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development a novel in silico mRNA vaccine against Clostridium difficile"],"prefix":"10.1016","volume":"24","author":[{"given":"Nasim","family":"Cheraghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Khoshnood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa","family":"Asadollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faezeh Sojoudi","family":"Ghamnak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Asadinezhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedayat","family":"Heydarizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazanin","family":"Omidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behrooz Sadeghi","family":"Kalani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgeb.2026.100771_bb0005","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s10096-019-03539-6","article-title":"Clostridium difficile infection","volume":"38","author":"Czepiel","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"7","key":"10.1016\/j.jgeb.2026.100771_bb0010","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.cmi.2019.10.023","article-title":"Clostridium difficile and one health","volume":"26","author":"Lim","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgeb.2026.100771_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13756-020-00815-5","article-title":"Antimicrobial resistance in Clostridioides (Clostridium) difficile derived from humans: a systematic review and meta-analysis","volume":"9","author":"Sholeh","year":"2020","journal-title":"Antimicrob Resist Infect Control"},{"issue":"02","key":"10.1016\/j.jgeb.2026.100771_bb0020","doi-asserted-by":"crossref","first-page":"049","DOI":"10.1055\/s-0040-1701229","article-title":"Clostridium difficile infection: an epidemiology update","volume":"33","author":"De Roo","year":"2020","journal-title":"Clin Colon Rectal Surg"},{"issue":"3","key":"10.1016\/j.jgeb.2026.100771_bb0025","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1053\/j.gastro.2019.04.053","article-title":"Fecal microbial transplantation for diseases beyond recurrent clostridium difficile infection","volume":"157","author":"D'Haens","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jgeb.2026.100771_bb0030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s40121-019-0231-8","article-title":"Clostridium difficile-associated diarrhea in developing countries: a systematic review and meta-analysis","volume":"8","author":"Curcio","year":"2019","journal-title":"Infect Dis Ther"},{"issue":"1\u20132","key":"10.1016\/j.jgeb.2026.100771_bb0035","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/07853890.2019.1701703","article-title":"Treatment of Clostridioides (Clostridium) difficile infection","volume":"52","author":"Jarmo","year":"2020","journal-title":"Ann Med"},{"issue":"6","key":"10.1016\/j.jgeb.2026.100771_bb0040","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41587-022-01294-2","article-title":"The clinical progress of mRNA vaccines and immunotherapies","volume":"40","author":"Barbier","year":"2022","journal-title":"Nat Biotechnol"},{"issue":"6","key":"10.1016\/j.jgeb.2026.100771_bb0045","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.7150\/ijbs.59233","article-title":"mRNA vaccines for COVID-19: what, why and how","volume":"17","author":"Park","year":"2021","journal-title":"Int J Biol Sci"},{"issue":"3","key":"10.1016\/j.jgeb.2026.100771_bb0050","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1053\/j.gastro.2004.11.004","article-title":"Clostridium difficile toxoid vaccine in recurrent C. Difficile-associated diarrhea","volume":"128","author":"Sougioultzis","year":"2005","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jgeb.2026.100771_bb0055","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1128\/IAI.71.3.1608-1610.2003","article-title":"Clostridium difficile vaccine and serum immunoglobulin G antibody response to toxin a","volume":"71","author":"Aboudola","year":"2003","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.jgeb.2026.100771_bb0060","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4161\/19490976.2014.969632","article-title":"Clostridium difficile virulence factors: insights into an anaerobic spore-forming pathogen","volume":"5","author":"Awad","year":"2014","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jgeb.2026.100771_bb0065","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S0924-8579(09)70012-3","article-title":"New trends in Clostridium difficile virulence and pathogenesis","volume":"33","author":"Deneve","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgeb.2026.100771_bb0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.anaerobe.2015.10.009","article-title":"Virulence factors of Clostridium difficile and their role during infection","volume":"37","author":"Janoir","year":"2016","journal-title":"Anaerobe"},{"issue":"7","key":"10.1016\/j.jgeb.2026.100771_bb0075","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nrmicro2164","article-title":"Clostridium difficile infection: new developments in epidemiology and pathogenesis","volume":"7","author":"Rupnik","year":"2009","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100771_bb0080","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10989-021-10359-w","article-title":"Immunoinformatics insights into the internalin a and B proteins to design a multi-epitope subunit vaccine for L. monocytogenes","volume":"28","author":"Asadollahi","year":"2022","journal-title":"Int J Pept Res Ther"},{"issue":"04","key":"10.1016\/j.jgeb.2026.100771_bb0085","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1055\/a-1713-3137","article-title":"In silico investigation of Lon protease as a promising therapeutic target","volume":"72","author":"Asadollahi","year":"2022","journal-title":"Drug Research"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100771_bb0090","first-page":"1","article-title":"In silico study of the proteins involved in the persistence of Brucella spp","volume":"20","author":"Asadollahi","year":"2023","journal-title":"Curr Drug Discov Technol"},{"key":"10.1016\/j.jgeb.2026.100771_bb0095","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10989-019-09868-6","article-title":"In silico insight into the dominant type II toxin\u2013antitoxin systems and Clp proteases in listeria monocytogenes and designation of derived peptides as a novel approach to interfere with this system","volume":"26","author":"Mohammadzadeh","year":"2020","journal-title":"Int J Pept Res Ther"},{"key":"10.1016\/j.jgeb.2026.100771_bb0100","first-page":"1","article-title":"Designing of multi-epitope peptide vaccine against Acinetobacter baumannii through combined immunoinformatics and protein interaction\u2013based approaches","author":"Dey","year":"2023","journal-title":"Immunol Res"},{"issue":"50","key":"10.1016\/j.jgeb.2026.100771_bb0105","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.1016\/j.vaccine.2019.02.052","article-title":"Status of vaccine research and development for Clostridium difficile","volume":"37","author":"Riley","year":"2019","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.jgeb.2026.100771_bb0110","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3390\/vaccines9020134","article-title":"HIV mRNA vaccines\u2014progress and future paths","volume":"9","author":"Mu","year":"2021","journal-title":"Vaccines"},{"issue":"5","key":"10.1016\/j.jgeb.2026.100771_bb0115","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S1473-3099(22)00764-2","article-title":"The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomized, placebo-controlled, dose-ranging, phase 1 clinical trials","volume":"23","author":"Essink","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jgeb.2026.100771_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104648","article-title":"Nonclinical safety assessment of repeated administration and biodistribution of a novel rabies self-amplifying mRNA vaccine in rats","volume":"113","author":"Stokes","year":"2020","journal-title":"Regul Toxicol Pharmacol"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100771_bb0125","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41541-021-00420-6","article-title":"Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza","volume":"6","author":"Chivukula","year":"2021","journal-title":"npj V2accines"},{"key":"10.1016\/j.jgeb.2026.100771_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2019.110632","article-title":"Immunosenescence: a systems-level overview of immune cell biology and strategies for improving vaccine responses","volume":"124","author":"Crooke","year":"2019","journal-title":"Exp Gerontol"},{"issue":"D1","key":"10.1016\/j.jgeb.2026.100771_bb0135","doi-asserted-by":"crossref","first-page":"D339","DOI":"10.1093\/nar\/gky1006","article-title":"The immune epitope database (IEDB): 2018 update","volume":"47","author":"Vita","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"14","key":"10.1016\/j.jgeb.2026.100771_bb0140","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1093\/bioinformatics\/btr335","article-title":"Immune system simulation online","volume":"27","author":"Rapin","year":"2011","journal-title":"Bioinformatics"}],"container-title":["Journal of Genetic Engineering and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X26001150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X26001150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:52:32Z","timestamp":1789559552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687157X26001150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1687157X26001150"],"URL":"https:\/\/doi.org\/10.1016\/j.jgeb.2026.100771","relation":{},"ISSN":["1687-157X"],"issn-type":[{"value":"1687-157X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development a novel in silico mRNA vaccine against Clostridium difficile","name":"articletitle","label":"Article Title"},{"value":"Journal of Genetic Engineering and Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgeb.2026.100771","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Academy of Scientific Research and Technology.","name":"copyright","label":"Copyright"}],"article-number":"100771"}}